Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.74
+0.14 (0.90%)
At close: Mar 6, 2026, 4:00 PM EST
15.44
-0.30 (-1.91%)
After-hours: Mar 6, 2026, 7:44 PM EST
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $929.86 million as of March 6, 2026. Its market cap has increased by 74.53% in one year.
Market Cap
929.86M
Enterprise Value
598.45M
1-Year Change
74.53%
Ranking
Category
Stock Price
$15.74
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $929.86M, an increase of 12.11%. That is a compound annual growth rate of 2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 929.86M | 52.08% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 992.28M |
| GH Research | 988.13M |
| Aktis Oncology | 987.94M |
| Geron | 980.03M |
| SELLAS Life Sciences Group | 941.66M |
| Valneva SE | 920.15M |
| Maravai LifeSciences Holdings | 912.59M |
| Fortrea Holdings | 898.54M |